Suzhou fujilai Pharmaceutical Co., Ltd
Initial public offering and listing on GEM
Announcement on online subscription and winning rate
Sponsor (co lead underwriter): Orient Securities Company Limited(600958) underwriting sponsor Co., Ltd
Co lead underwriter: Guotai Junan Securities Co.Ltd(601211)
hot tip
The application of Suzhou fujilai Pharmaceutical Co., Ltd. (hereinafter referred to as “fujilai”, “issuer” or “company”) for initial public offering of no more than 22.92 million ordinary shares (A shares) and listing on the gem (hereinafter referred to as “this offering”) has been examined and approved by the GEM Listing Committee of Shenzhen Stock Exchange (hereinafter referred to as “Shenzhen Stock Exchange”), It has been registered by China Securities Regulatory Commission (hereinafter referred to as “CSRC”) (zjxk [2022] No. 251).
The sponsor (co lead underwriter) of this offering is Orient Securities Company Limited(600958) underwriting sponsor Co., Ltd. (hereinafter referred to as “sponsor (co lead underwriter)” or “China Eastern Investment Bank“), Guotai Junan Securities Co.Ltd(601211) (hereinafter referred to as ” Guotai Junan Securities Co.Ltd(601211) “) is the co lead underwriter of this offering (China Eastern Investment Bank and Guotai Junan Securities Co.Ltd(601211) ) are collectively referred to as “co lead underwriters”). The issuer and the joint lead underwriters negotiated and determined that the number of shares issued this time is 22.92 million shares. The issue price is 48.30 yuan / share. The issuing price of this offering shall not exceed the median and weighted average of offline investors’ quotation after excluding the highest quotation, as well as the securities investment fund, national social security fund, basic old-age insurance fund established through public offering after excluding the highest quotation The enterprise annuity fund established in accordance with the measures for the administration of enterprise annuity fund and the insurance fund quotation median and weighted average in accordance with the measures for the administration of the use of insurance funds, etc., whichever is lower, so the relevant subsidiaries of the sponsor need not participate in the strategic placement. This offering does not arrange strategic placement to other external investors. Finally, this offering will not be placed to strategic investors. The difference between the initial strategic placement and the final strategic placement was 1146000 shares, which were transferred back to offline issuance.
This offering is conducted through a combination of offline inquiry and placement to qualified offline investors (hereinafter referred to as “offline issuance”) and online pricing issuance to social public investors holding non restricted A-share shares and non restricted depositary receipts in Shenzhen market (hereinafter referred to as “online issuance”).
After the strategic placement call back and before the online and offline call back mechanism was launched, the initial offline issuance amount was 28.50% of 16.388 million. The total number of final offline and online issuance is 22.92 million shares, and the final number of online and offline issuance will be determined according to the callback.
The issuer initially issued 6.532 million shares of “fujilai” through the online pricing of the trading system of Shenzhen Stock Exchange on March 17, 2022 (t day).
Investors are kindly requested to focus on the payment process of this offering and fulfill their payment obligations on March 21, 2022 (T + 2):
1. According to the announcement of initial public offering and initial placement results of offline issuance of Suzhou fujilai Pharmaceutical Co., Ltd. listed on the gem disclosed on March 21, 2022 (T + 2), the offline allocated investors shall timely and fully pay the subscription funds for new shares before 16:00 on March 21, 2022 (T + 2) according to the finally determined issuance price and allocated quantity.
The subscription funds shall be paid in full within the specified time. If the subscription funds are not paid in full within the specified time or as required, all the new shares allocated to the placing object shall be invalid. If the above-mentioned circumstances occur when multiple new shares are issued on the same day, all the placing objects are invalid. If different placing objects share bank accounts, if the subscription funds are insufficient, all the new shares allocated to the placing objects sharing bank accounts will be invalid. Offline investors are allocated multiple new shares on the same day. Please pay for each new share separately.
After winning the subscription of new shares, online investors shall fulfill the obligation of capital settlement in accordance with the announcement on the results of initial public offering and online lottery of Suzhou fujilai Pharmaceutical Co., Ltd. listed on the gem, so as to ensure that their capital account has sufficient capital for subscription of new shares by the end of March 21 (T + 2) 2022. The insufficient part shall be deemed to have given up the subscription, and the consequences and relevant legal liabilities arising therefrom shall be borne by the investors themselves. The transfer of investors’ funds shall comply with the relevant provisions of the securities company where the investors are located.
The shares that offline and online investors give up to subscribe for are underwritten by the sponsor (joint lead underwriter). 2. Among the stocks issued this time, the stocks issued online have no circulation restrictions and limited sales period arrangements, and can be circulated from the date when the stocks issued this time are listed on the Shenzhen Stock Exchange.
The offline issuance part adopts the proportional sales restriction method, and the offline investors shall promise that the sales restriction period of 10% (rounded up) of the number of shares allocated to them is 6 months from the date of the issuer’s initial public offering and listing. That is, among the shares allocated to each placing object, 90% of the shares are sold indefinitely and can be circulated from the date when the issued shares are listed and traded on the Shenzhen Stock Exchange; The sales restriction period of 10% of the shares is 6 months, and the sales restriction period starts from the date when the issued shares are listed and traded on the Shenzhen Stock Exchange.
When offline investors participate in the preliminary inquiry and quotation and offline purchase, they do not need to fill in the arrangement of the restricted sale period for the placing objects under their management. Once the quotation is made, it is deemed to accept the arrangement of the online restricted sale period disclosed in this announcement.
3. When the total number of shares paid and subscribed by offline and online investors is less than 70% of the number of this public offering, the issuer and the joint lead underwriter will suspend the issuance of new shares and disclose the reasons for the suspension and subsequent arrangements.
4. If the offline investors who provide effective quotation fail to participate in the subscription or the offline investors who obtain the preliminary placement fail to pay the subscription amount in time and in full, it will be deemed as a breach of contract and shall bear the liability for breach of contract. The joint lead underwriters shall report the breach to the China Securities Association for the record. The number of violations of placing objects in various sectors of the stock market of Beijing stock exchange (hereinafter referred to as “Beijing stock exchange”), Shanghai Stock Exchange (hereinafter referred to as “Shanghai Stock Exchange”) and Shenzhen Stock Exchange shall be calculated together. During the period of being included in the restricted list, the placing object shall not participate in the offline inquiry and placement of relevant projects in all sectors of the stock market of Beijing stock exchange, Shanghai Stock Exchange and Shenzhen Stock Exchange.
If online investors fail to pay in full after winning the lottery for three times in a row within 12 months, they shall not participate in the online subscription of new shares, depositary receipts, convertible corporate bonds and exchangeable corporate bonds within 6 months (calculated as 180 natural days, including the next day) from the next day of the settlement participant’s latest declaration of abandonment of subscription. The number of times of giving up subscription shall be calculated according to the number of times of investors actually giving up subscription of new shares, depositary receipts, convertible corporate bonds and exchangeable corporate bonds.
1、 Online subscription and initial winning rate of online issuance
According to the data provided by Shenzhen Stock Exchange, the joint lead underwriters have made statistics on the subscription of this online offering. The number of effective subscription accounts of this online pricing offering is 12449090, the number of effective subscription shares is 67126430500, the total number of allotments is 134252861, the starting number of allotments is 000000 Ping An Bank Co.Ltd(000001) , and the ending number is 000134252861.
2、 Implementation of callback mechanism, issuance structure and final winning rate of online issuance
According to the callback mechanism announced in the announcement of Suzhou fujilai Pharmaceutical Co., Ltd. initial public offering and listing on the gem, since the initial effective subscription multiple on the Internet is 1027655090 times, higher than 100 times, the issuer and the joint lead underwriters decided to start the callback mechanism and callback 20% (rounded up to an integral multiple of 500 shares, i.e. 4584000 shares) of the number of shares issued this time from the Internet to the Internet. After the call back, the final number of offline shares issued was 11.804 million, accounting for 51.50% of the total issued this time; The final number of shares issued online was 11.116 million, accounting for 48.50% of the total issued this time. After the call back, the winning rate of this online pricing issuance was 00165597961%, and the subscription multiple was 603872171 times.
3、 Online lottery
The issuer and the co lead underwriters agreed to conduct lottery in Room 202, building 203, Shangbu Industrial Zone, Hongli West Road, Futian District, Shenzhen on the morning of March 18, 2022 (T + 1), and will publish the online lottery results in China Securities News, Shanghai Securities News, securities times and securities daily on March 21, 2022 (T + 2).
Issuer: sponsor of Suzhou fujilai Pharmaceutical Co., Ltd. (co lead underwriter): Orient Securities Company Limited(600958) underwriting sponsor co lead underwriter: Guotai Junan Securities Co.Ltd(601211) March 18, 2022 (seal page of the announcement on the online subscription and winning rate of Suzhou fujilai Pharmaceutical Co., Ltd. in its initial public offering and listing on the GEM)
Suzhou fujilai Pharmaceutical Co., Ltd. (no text on this page, which is the seal page of the announcement on the online subscription and winning rate of Suzhou fujilai Pharmaceutical Co., Ltd. in its initial public offering and listing on the GEM)
Orient Securities Company Limited(600958) underwriting and recommendation Co., Ltd. (this page has no text, which is the seal page of the announcement on the online subscription and winning rate of Suzhou fujilai Pharmaceutical Co., Ltd. in its initial public offering and listing on the GEM)
Guotai Junan Securities Co.Ltd(601211) mm / DD / yyyy
